Sun Yat-sen University Cancer Center

Trial Profile

Sun Yat-sen University Cancer Center

Phase of Trial: Phase II

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs Capecitabine (Primary) ; Lapatinib (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
    • 08 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Apr 2018.
    • 18 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top